BioCryst Pharmaceuticals, Inc. (BCRX)

NASDAQ: BCRX · Real-Time Price · USD

8.62

-0.28 (-3.15%)

At close: May 8, 2026, 4:00 PM EDT

8.60

-0.02 (-0.22%)

After-hours: May 8, 2026, 7:44 PM EDT

BioCryst Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	171.59	89.74	104.71	110.64	304.77	504.39
Short-Term Investments	66.81	185.01	216.14	278.34	119.54	3.21
Cash & Short-Term Investments	238.4	274.75	320.85	388.99	424.31	507.6
Cash Growth	-19.21%	-14.37%	-17.52%	-8.33%	-16.41%	68.99%
Accounts Receivable	109.27	106.82	79.07	56.95	50.6	29.41
Inventory	5.99	5.4	8.09	28.68	27.53	15.79
Other Current Assets	19.97	17.38	13.96	21.35	14.06	13.33
Total Current Assets	373.63	404.35	421.97	495.97	516.5	566.14
Net Property, Plant & Equipment	22.99	18.99	19.79	20.91	8.62	8.71
Long-Term Investments	20.57	61.16	20.32	-	18.08	6.83
Other Long-Term Assets	47.87	29.66	28.34	0.08	6.81	6.47
Total Assets	465.05	514.16	490.42	516.96	550	588.15
Accounts Payable	10.96	15.83	11.64	20.89	14.36	27.81
Accrued Expenses	119.4	126.41	113.29	102.88	87.57	72.67
Short-Term Debt	40.32	38.46	32.68	23.57	-	-
Current Portion of Leases	8.5	1.63	2.77	2.65	3.59	3.24
Unearned Revenue	5.41	-	-	-	1.22	1.42
Other Current Liabilities	16.22	13.74	-	-	-	-
Total Current Liabilities	195.39	196.07	160.38	149.99	105.51	103.72
Long-Term Debt	802.38	427.23	795.92	811.27	733.28	585.46
Long-Term Leases	12.3	10.01	10.05	11.24	5.8	5.96
Other Long-Term Liabilities	8.83	-	-	-	-	-
Total Long-Term Liabilities	823.5	437.25	805.97	822.5	739.08	591.42
Total Liabilities	1,019	633.31	966.35	972.49	844.6	695.14
Common Stock	2.54	2.13	2.09	2.06	1.88	1.84
Additional Paid-in Capital	1,672	1,385	1,291	1,222	1,158	1,099
Accumulated Other Comprehensive Income	-0.37	0.04	0.92	1.34	0.03	0.18
Retained Earnings	-2,228	-1,506	-1,770	-1,681	-1,455	-1,208
Shareholders' Equity	-553.84	-119.15	-475.93	-455.53	-294.6	-106.99
Total Liabilities & Equity	465.05	514.16	490.42	516.96	550	588.15
Total Debt	863.49	477.33	841.42	848.71	742.68	594.66
Net Cash (Debt)	-625.09	-202.58	-520.57	-459.73	-318.37	-87.06
Net Cash Per Share	-2.77	-0.93	-2.52	-2.39	-1.71	-0.49
Book Value	-553.84	-119.15	-475.93	-455.53	-294.6	-106.99
Book Value Per Share	-2.46	-0.55	-2.30	-2.37	-1.58	-0.60
Tangible Book Value	-553.84	-119.15	-475.93	-455.53	-294.6	-106.99
Tangible Book Value Per Share	-2.46	-0.55	-2.30	-2.37	-1.58	-0.60

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q